Literature DB >> 15945591

The differentiation of mild frontotemporal dementia from Alzheimer's disease and healthy aging by neuropsychological tests.

Alexandra J Walker1, Susanne Meares, Perminder S Sachdev, Henry Brodaty.   

Abstract

BACKGROUND: Frontotemporal dementia (FTD) is difficult to diagnose in the early stages and may be misdiagnosed as Alzheimer's disease (AD) or as a psychiatric disorder. This study aimed to investigate neuropsychological function in FTD of mild severity and compare it to that of mild AD and healthy control participants.
METHODS: The study comprised 11 individuals with FTD, 29 with AD and 27 healthy controls. Participants completed a comprehensive neuropsychological assessment in which each area of cognitive function was examined with several widely used clinical tests. Test scores were converted to age-corrected scaled scores and combined to form indices for six areas of cognitive function. These indices were attention, psychomotor speed, memory acquisition, memory recall, executive function and constructional ability.
RESULTS: The FTD group performed below the level of the controls in all areas except constructional ability. FTD and AD groups showed distinct patterns of neuropsychological performance. The FTD group showed predominantly executive dysfunction with less impaired memory function, while the AD group showed the opposite pattern. The capacity of the tests to discriminate between groups was good overall, with 90% of the total sample correctly classified. Predictive success for the FTD group was 64%, given a base rate of 16%.
CONCLUSION: Administration of a comprehensive neuropsychological protocol including several tests of executive function allows increased certainty about accurate clinical diagnosis of mild FTD.

Entities:  

Mesh:

Year:  2005        PMID: 15945591     DOI: 10.1017/s1041610204000778

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  15 in total

1.  Relationship between executive functioning and activities of daily living in patients with relatively mild dementia.

Authors:  Jill Razani; Rachel Casas; Jennifer T Wong; Po Lu; Cathy Alessi; Karen Josephson
Journal:  Appl Neuropsychol       Date:  2007

2.  The free and cued selective reminding test distinguishes frontotemporal dementia from Alzheimer's disease.

Authors:  Raquel Lemos; Diana Duro; Mário R Simões; Isabel Santana
Journal:  Arch Clin Neuropsychol       Date:  2014-07-25       Impact factor: 2.813

Review 3.  Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review.

Authors:  A D Hutchinson; J L Mathias
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

4.  Analyzing theory of mind impairment in patients with behavioral variant frontotemporal dementia.

Authors:  Anna Rita Giovagnoli; Brian Bell; Alessandra Erbetta; Chiara Paterlini; Orso Bugiani
Journal:  Neurol Sci       Date:  2019-05-11       Impact factor: 3.307

Review 5.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 6.  Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration.

Authors:  Katya Rascovsky; Murray Grossman
Journal:  Int Rev Psychiatry       Date:  2013-04

7.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

Authors:  Katya Rascovsky; John R Hodges; David Knopman; Mario F Mendez; Joel H Kramer; John Neuhaus; John C van Swieten; Harro Seelaar; Elise G P Dopper; Chiadi U Onyike; Argye E Hillis; Keith A Josephs; Bradley F Boeve; Andrew Kertesz; William W Seeley; Katherine P Rankin; Julene K Johnson; Maria-Luisa Gorno-Tempini; Howard Rosen; Caroline E Prioleau-Latham; Albert Lee; Christopher M Kipps; Patricia Lillo; Olivier Piguet; Jonathan D Rohrer; Martin N Rossor; Jason D Warren; Nick C Fox; Douglas Galasko; David P Salmon; Sandra E Black; Marsel Mesulam; Sandra Weintraub; Brad C Dickerson; Janine Diehl-Schmid; Florence Pasquier; Vincent Deramecourt; Florence Lebert; Yolande Pijnenburg; Tiffany W Chow; Facundo Manes; Jordan Grafman; Stefano F Cappa; Morris Freedman; Murray Grossman; Bruce L Miller
Journal:  Brain       Date:  2011-08-02       Impact factor: 13.501

Review 8.  Modes of Aβ toxicity in Alzheimer's disease.

Authors:  Jürgen Götz; Anne Eckert; Miriam Matamales; Lars M Ittner; Xin Liu
Journal:  Cell Mol Life Sci       Date:  2011-06-25       Impact factor: 9.261

9.  Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND).

Authors:  Blossom Cm Stephan; Fiona E Matthews; Kay-Tee Khaw; Carole Dufouil; Carol Brayne
Journal:  Alzheimers Res Ther       Date:  2009-07-09       Impact factor: 6.982

10.  Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.

Authors:  M Degerman Gunnarsson; M Lindau; A F Santillo; A Wall; H Engler; L Lannfelt; H Basun; L Kilander
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.